Adverum Biotechnologies, Inc.
ADVM
$2.91
-$0.06-2.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.69M | 153.24M | 173.83M | 193.33M | 96.53M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.61M | 7.84M | 5.59M | 5.80M | 6.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 131.30M | 161.08M | 179.42M | 199.13M | 102.77M |
|
|
|||||
| Total Current Assets | 131.30M | 161.08M | 179.42M | 199.13M | 102.77M |
| Net Property, Plant & Equipment | 45.22M | 62.91M | 64.28M | 65.53M | 49.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.32M | 10.39M | 10.10M | 3.17M | 3.21M |
| Total Assets | 179.84M | 234.38M | 253.80M | 267.83M | 155.77M |
|
|
|||||
| Total Accounts Payable | 1.61M | 2.11M | 1.97M | 1.90M | 1.92M |
| Total Accrued Expenses | 14.50M | 13.66M | 9.20M | 8.14M | 11.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.67M | 10.66M | 10.58M | 10.49M | 5.48M |
| Total Finance Division Other Current Liabilities | 1.13M | 1.23M | 710.00K | 1.02M | 826.00K |
| Total Other Current Liabilities | 1.13M | 1.23M | 710.00K | 1.02M | 826.00K |
| Total Current Liabilities | 22.90M | 27.66M | 22.46M | 21.55M | 19.98M |
|
|
|||||
| Total Current Liabilities | 22.90M | 27.66M | 22.46M | 21.55M | 19.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 86.04M | 62.60M | 63.31M | 63.99M | 68.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 192.00K | -- | -- | -- | -- |
| Total Liabilities | 109.13M | 90.26M | 85.77M | 85.54M | 88.55M |
|
|
|||||
| Common Stock & APIC | 1.14B | 1.13B | 1.13B | 1.13B | 1.00B |
| Retained Earnings | -1.07B | -990.17M | -963.04M | -944.56M | -936.02M |
| Treasury Stock & Other | -407.00K | -268.00K | -525.00K | -533.00K | -473.00K |
| Total Common Equity | 70.71M | 144.12M | 168.03M | 182.29M | 67.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 70.71M | 144.12M | 168.03M | 182.29M | 67.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 70.71M | 144.12M | 168.03M | 182.29M | 67.22M |
|
|
|||||